HIF-1 alpha Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer

Purpose: Preoperative concurrent chemoradiotherapy (CCRT) is the standard treatment for locally advanced rectal cancer patients. However, the poor therapeutic efficacy of CCRT was found in rectal cancer patients with hyperglycemia. This study investigated how hyperglycemia affects radiochemotherapy resistance in rectal cancer. Methods and Materials: We analyzed the correlation between prognosis indexes with hypoxia-inducible factor-1 alpha (HIF-1 alpha) in rectal cancer patients with preoperative CCRT. In vitro, we investigated the effect of different concentrated glucose of environments on the radiation tolerance of rectal cancers. Further, we analyzed the combined HIF-1 alpha inhibitor with radiation therapy in hyperglycemic rectal cancers. Results: The prognosis indexes of euglycemic or hyperglycemic rectal cancer patients after receiving CCRT treatment were investigated. The hyperglycemic rectal cancer patients (n = 13, glycosylated hemoglobin, HbA1c > 6.5%) had poorer prognosis indexes. In addition, a positive correlation was observed between HIF-1 alpha expression and HbA1c levels (p = 0.046). Therefore, it is very important to clarify the relationship between HIF-1 alpha and poor response in patients with hyperglycemia receiving pre-operative CCRT. Under a high glucose environment, rectal cancer cells express higher levels of glucose transport 1 (GLUT1), O-GlcNAc transferase (OGT), and HIF-1 alpha, suggesting that the high glucose environment might stimulate HIF-1 alpha expression through the GLUT1-OGT-HIF-1 alpha pathway promoting tolerance to Fluorouracil (5-FU) and radiation. In the hyperglycemic rectal cancer animal model, rectal cancer cells confirmed that radiation exposure reduces apoptosis by overexpressing HIF-1 alpha. Combining HIF-1 alpha inhibitors was able to reverse radioresistance in a high glucose environment. Lower HIF-1 alpha levels increased DNA damage in tumors leading to apoptosis. Conclusions: The findings here show that hyperglycemia induces the expression of GLUT1, OGT, and HIF-1 alpha to cause CCRT tolerance in rectal cancer and suggest that combining HIF-1 alpha inhibitors could reverse radioresistance in a high glucose environment. HIF-1 alpha inhibitors may be useful for development as CCRT sensitizers in patients with hyperglycemic rectal cancer.

Automated summary

This study examined the impact of hyperglycemia on radiochemotherapy resistance in patients with rectal cancer. It found that rectal cancer patients with hyperglycemia had poorer prognosis indicators. In a high glucose environment, rectal cancer cells expressed higher levels of GLUT1, OGT, and HIF-1 alpha, promoting tolerance to chemotherapy and radiation. However, combining HIF-1 alpha inhibitors could reverse radioresistance in hyperglycemic rectal cancer. Lower levels of HIF-1 alpha increased DNA damage in tumors and induced apoptosis.